COMPANY INFORMATION Inavya Ventures Ltd is a London-based Start-up that specialises in AI and medicine. Inavya has developed AVATR - a regulated medical-grade device that connects to other medical devices - plus environmental, social and behavioural data - to enable people to live well when outside of hospital. As a novel Augmented Intelligence and Machine Learning system, AVATR is designed to deliver personalised medicine at scale and beyond borders. Inavya seeks collaboration partners in China to develop AI, IoT and medicine demonstrators outside of hospital. BUSINESS HIGHLIGHTS - Clinical demonstrators of AVATR are currently running at - National Heart Centre in Singapore; - Albert Einstein Hospital in São Paulo where Inavya is leading on a Brazil-UK Newton Fund project Funding received from UK Government and Private Investors STRATEGIC VALUE AVATR connects the patient through a chatbot - and doctor through a dashboard - giving them both direct control of the data they exchange, whilst respecting their data privacy and security. The patient is reassured and benefits from continuous medical-grade monitoring while outside of hospital; meanwhile, their doctor is able to receive highly relevant real-time data to inform clinical decisions that improve health outcomes and reduce costs.